123 related articles for article (PubMed ID: 3537044)
1. Immunohistochemical study of HLA antigens and lymphocyte infiltration in melanocytic tumors.
Kageshita T; Nagano H; Johno M; Ono T; Arao T; Imai K
J Dermatol; 1986 Jun; 13(3):179-84. PubMed ID: 3537044
[No Abstract] [Full Text] [Related]
2. [Expression of HLA-Dr and CD1+ cells in malignant and benign pigmentary tumors].
Ramírez-Bosca A; Valcuende-Cavero F; Rufat-Pérez MJ; Castells-Rodellas A
Med Cutan Ibero Lat Am; 1989; 17(1):58-64. PubMed ID: 2474114
[TBL] [Abstract][Full Text] [Related]
3. Antigenic phenotype of pigment cell lesions: a study of melanoma, its precursor lesions and heterogeneity in metastatic melanoma.
Ernstoff MS; Duray P; Stenn K; Kirkwood JM
J Invest Dermatol; 1985 May; 84(5):430-2. PubMed ID: 3889169
[TBL] [Abstract][Full Text] [Related]
4. Antigens associated with tumor progression in melanocytic neoplasia.
Elder DE; Herlyn M
Pigment Cell Res; 1992; Suppl 2():136-43. PubMed ID: 1409415
[No Abstract] [Full Text] [Related]
5. Multiple agminate Spitz naevi: review of the literature and report of a case with distinctive immunohistological features.
Hamm H; Happle R; Bröcker EB
Br J Dermatol; 1987 Oct; 117(4):511-22. PubMed ID: 3314974
[TBL] [Abstract][Full Text] [Related]
6. HLA-DR and 96-K antigens and intratumoral lymphocytic infiltrate in primary cutaneous melanoma as markers of tumor progression.
Brogelli L; Moretti S; Borgognoni L; Giannotti B
Dermatologica; 1990; 180(2):69-72. PubMed ID: 2311798
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens.
Ruiter DJ; Bergman W; Welvaart K; Scheffer E; van Vloten WA; Russo C; Ferrone S
Cancer Res; 1984 Sep; 44(9):3930-5. PubMed ID: 6204749
[TBL] [Abstract][Full Text] [Related]
8. Differentiation between B cells, T cells, and histiocytes in melanocytic lesions: primary and metastatic melanoma and halo and giant pigmented nevi.
Edelson RL; Hearing VJ; Dellon AL; Frank M; Edelson EK; Green I
Clin Immunol Immunopathol; 1975 Nov; 4(4):557-68. PubMed ID: 1081937
[No Abstract] [Full Text] [Related]
9. Desmoplastic melanocytic nevi with lymphocytic aggregates.
Kiuru M; Patel RM; Busam KJ
J Cutan Pathol; 2012 Oct; 39(10):940-4. PubMed ID: 22845683
[TBL] [Abstract][Full Text] [Related]
10. Immunohistological evaluation of MHC class I and II antigen expression on nevi and melanoma: relation to biology of melanoma.
D'Alessandro G; Zardawi I; Grace J; McCarthy WH; Hersey P
Pathology; 1987 Oct; 19(4):339-46. PubMed ID: 3328139
[TBL] [Abstract][Full Text] [Related]
11. Dermoscopy, reflectance confocal microscopy and immunohistochemical analysis in melanocytic lesions with Meyerson's phenomenon.
Oliveira A; Arzberger E; Massone C; Fink-Puches R; Zalaudek I; Hofmann-Wellenhof R
Dermatology; 2014; 229(4):297-305. PubMed ID: 25472722
[TBL] [Abstract][Full Text] [Related]
12. Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma.
Ruiter DJ; Bhan AK; Harrist TJ; Sober AJ; Mihm MC
J Immunol; 1982 Dec; 129(6):2808-15. PubMed ID: 6183345
[TBL] [Abstract][Full Text] [Related]
13. [Identification of protein S 100 and melanoma-associated antigens in a comparative study of malignant melanoma and nevus pathology].
Monti M; Berti E; Cavicchini S; Paindelli MG; Terragni L
G Ital Dermatol Venereol; 1985; 120(4):297-306. PubMed ID: 3899920
[No Abstract] [Full Text] [Related]
14. Update on immunohistochemistry in melanocytic lesions.
Ferringer T
Dermatol Clin; 2012 Oct; 30(4):567-79, v. PubMed ID: 23021046
[TBL] [Abstract][Full Text] [Related]
15. In situ analysis of the mononuclear cell infiltrate in primary malignant melanoma of the skin.
Poppema S; Bröcker EB; de Leij L; Terbrack D; Visscher T; Ter Haar A; Macher E; Thé TH; Sorg C
Clin Exp Immunol; 1983 Jan; 51(1):77-82. PubMed ID: 6219841
[TBL] [Abstract][Full Text] [Related]
16. Presence of activated lymphocytes in the peripheral blood of patients with halo nevi.
Baranda L; Torres-Alvarez B; Moncada B; Portales-Pérez D; de la Fuente H; Layseca E; González-Amaro R
J Am Acad Dermatol; 1999 Oct; 41(4):567-72. PubMed ID: 10495377
[TBL] [Abstract][Full Text] [Related]
17. Antigenic profile of tumor progression stages in human melanocytic nevi and melanomas.
Elder DE; Rodeck U; Thurin J; Cardillo F; Clark WH; Stewart R; Herlyn M
Cancer Res; 1989 Sep; 49(18):5091-6. PubMed ID: 2548711
[TBL] [Abstract][Full Text] [Related]
18. Association between sialyl Lewis(a) expression and tumor progression in melanoma.
Kageshita T; Hirai S; Kimura T; Hanai N; Ohta S; Ono T
Cancer Res; 1995 Apr; 55(8):1748-51. PubMed ID: 7712483
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical characterization of Spitz's nevus: differentiation from common melanocytic nevus, dysplastic melanocytic nevus and malignant melanoma.
Takahashi H; Maeda K; Maeda K; Akutsu Y; Horikoshi T; Jimbow K
J Dermatol; 1987 Dec; 14(6):533-41. PubMed ID: 3329652
[No Abstract] [Full Text] [Related]
20. Epithelial membrane antigen staining of melanocytic nevi.
Cramer SF
Hum Pathol; 1990 Jan; 21(1):121-2. PubMed ID: 2295503
[No Abstract] [Full Text] [Related]
[Next] [New Search]
